Cargando…

Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer’s disease from normal cognitive aging

BACKGROUND: A critical and as-yet unmet need in Alzheimer disease (AD) research is the development of novel markers that can identify individuals at risk for cognitive decline due to AD. This would aid intervention trials designed to slow the progression of AD by increasing diagnostic certainty, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Motsinger-Reif, Alison A, Zhu, Hongjie, Kling, Mitchel A, Matson, Wayne, Sharma, Swati, Fiehn, Oliver, Reif, David M, Appleby, Dina H, Doraiswamy, P Murali, Trojanowski, John Q, Kaddurah-Daouk, Rima, Arnold, Steven E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893491/ https://www.ncbi.nlm.nih.gov/pubmed/24252434 http://dx.doi.org/10.1186/2051-5960-1-28

Ejemplares similares

Alterations in metabolic pathways and networks in Alzheimer's disease
por: Kaddurah-Daouk, R, et al.
Publicado: (2013)

Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants
por: Rotroff, D M, et al.
Publicado: (2016)

Pharmacometabolomic Assessment of Metformin in Non-diabetic, African Americans
por: Rotroff, Daniel M., et al.
Publicado: (2016)

Pharmacometabolomics of Response to Sertraline and to Placebo in Major Depressive Disorder – Possible Role for Methoxyindole Pathway
por: Zhu, Hongjie, et al.
Publicado: (2013)

Metabolomics Reveals Amino Acids Contribute to Variation in Response to Simvastatin Treatment
por: Trupp, Miles, et al.
Publicado: (2012)

Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics
por: Han, Xianlin, et al.
Publicado: (2011)

Sphingolipid Metabolic Pathway Impacts Thiazide Diuretics Blood Pressure Response: Insights From Genomics, Metabolomics, and Lipidomics
por: Shahin, Mohamed H., et al.
Publicado: (2017)

The steroid metabolome in women with premenstrual dysphoric disorder during GnRH agonist-induced ovarian suppression: effects of estradiol and progesterone addback
por: Nguyen, T V, et al.
Publicado: (2017)

ApoJ/Clusterin concentrations are determinants of cerebrospinal fluid cholesterol efflux capacity and reduced levels are associated with Alzheimer’s disease
por: Ko, Yi-An, et al.
Publicado: (2022)

Metabolic Profiling of Patients with Schizophrenia
por: Kaddurah-Daouk, Rima
Publicado: (2006)

Bile acids targeted metabolomics and medication classification data in the ADNI1 and ADNIGO/2 cohorts
por: St. John-Williams, Lisa, et al.
Publicado: (2019)

Associations between purine metabolites and monoamine neurotransmitters in first-episode psychosis
por: Yao, Jeffrey K., et al.
Publicado: (2013)

Pharmacometabolomic Assessments of Atenolol and Hydrochlorothiazide Treatment Reveal Novel Drug Response Phenotypes
por: Rotroff, DM, et al.
Publicado: (2015)

Cerebrospinal Fluid Metabolome in Mood Disorders-Remission State has a Unique Metabolic Profile
por: Kaddurah-Daouk, Rima, et al.
Publicado: (2012)

Pharmacometabolomics Informs About Pharmacokinetic Profile of Methylphenidate
por: Kaddurah‐Daouk, Rima, et al.
Publicado: (2018)

The Metabolome-Wide Signature of Major Depressive Disorder
por: Jansen, Rick, et al.
Publicado: (2023)

Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer’s disease and progressive supranuclear palsy
por: Batra, Richa, et al.
Publicado: (2023)

The effect of alternative permutation testing strategies on the performance of multifactor dimensionality reduction
por: Motsinger-Reif, Alison A
Publicado: (2008)

Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study
por: Varma, Vijay R., et al.
Publicado: (2018)

Sets of coregulated serum lipids are associated with Alzheimer's disease pathophysiology
por: Barupal, Dinesh Kumar, et al.
Publicado: (2019)

Targeted metabolomics and medication classification data from participants in the ADNI1 cohort
por: St John-Williams, Lisa, et al.
Publicado: (2017)

Serum metabolomic biomarkers of perceptual speed in cognitively normal and mildly impaired subjects with fasting state stratification
por: Borkowski, Kamil, et al.
Publicado: (2021)

An Introduction to Terminology and Methodology of Chemical Synergy—Perspectives from Across Disciplines
por: Roell, Kyle R., et al.
Publicado: (2017)

Evaluation of calling algorithms for array-CGH
por: Roy, Siddharth, et al.
Publicado: (2013)

Beyond IC(50)s: Towards Robust Statistical Methods for in vitro Association Studies
por: Beam, Andrew, et al.
Publicado: (2014)

Prediction of synergistic drug combinations using PCA-initialized deep learning
por: Ma, Jun, et al.
Publicado: (2021)

Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers
por: Nho, Kwangsik, et al.
Publicado: (2019)

Homeostatic Imbalance of Purine Catabolism in First-Episode Neuroleptic-Naïve Patients with Schizophrenia
por: Yao, Jeffrey K., et al.
Publicado: (2010)

Serum metabolites associated with brain amyloid beta deposition, cognition and dementia progression
por: Nho, Kwangsik, et al.
Publicado: (2021)

Circular-SWAT for deep learning based diagnostic classification of Alzheimer's disease: application to metabolome data
por: Jo, Taeho, et al.
Publicado: (2023)

Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients
por: Bhattacharyya, Sudeepa, et al.
Publicado: (2019)

Evaluation of genetic risk score models in the presence of interaction and linkage disequilibrium
por: Che, Ronglin, et al.
Publicado: (2013)

Current Concepts in Pharmacometabolomics, Biomarker Discovery, and Precision Medicine
por: Beger, Richard D., et al.
Publicado: (2020)

ToxPi*GIS Toolkit: Creating, viewing, and sharing integrative visualizations for geospatial data using ArcGIS
por: Fleming, Jonathon, et al.
Publicado: (2021)

Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome
por: Arnold, Matthias, et al.
Publicado: (2020)

Associations between Purine Metabolites and Clinical Symptoms in Schizophrenia
por: Yao, Jeffrey K., et al.
Publicado: (2012)

Gut Microbiome-Linked Metabolites in the Pathobiology of Major Depression With or Without Anxiety—A Role for Bile Acids
por: MahmoudianDehkordi, Siamak, et al.
Publicado: (2022)

Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics
por: Liu, Duan, et al.
Publicado: (2018)

A comparison of internal model validation methods for multifactor dimensionality reduction in the case of genetic heterogeneity
por: Gory, Jeffrey J, et al.
Publicado: (2012)

Neural networks for genetic epidemiology: past, present, and future
por: Motsinger-Reif, Alison A, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_uqgspk105vm16r5kegcoci211a